Skip to main content
https://pbs.twimg.com/media/EmJv1MhWMAEKUTb.jpg
PsA pts have ^ risk of developing polyclonal gammopathy, MGUS, and possibly progression to lymphoproliferative malignancy. #ABS0338 #ACR20 @RheumNow https://t.co/jl6sq1KcKZ https://t.co/BHrGKPXs3a
Dr. Rachel Tate
06-11-2020
×